Viridian Therapeutics, Inc.\DE (VRDN) Treasury Shares (2015 - 2016)

Viridian Therapeutics, Inc.\DE's Treasury Shares history runs 8 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 45.2% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 45.2% YoY), while the FY2025 annual figure was $1.1 million, up 238.89% from the prior year.
• Treasury Shares for Q1 2026 stood at $1.6 million, up from $1.1 million in the prior quarter.
• The five-year high for Treasury Shares was $1.6 million in Q1 2026, with the low at $250000.0 in Q1 2023.
• The 4-year median for Treasury Shares is $804947.0 (2023), against an average of $838860.6.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares tumbled 60.98% in 2024, then surged 238.89% in 2025.
• Viridian Therapeutics, Inc.\DE's Treasury Shares stood at $804947.0 in 2023, then sank by 60.98% to $314075.0 in 2024, then soared by 238.89% to $1.1 million in 2025, then jumped by 53.95% to $1.6 million in 2026.
• Business Quant data shows VRDN's Treasury Shares at $1.6 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.